Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma: A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose

Strahlentherapie und Onkologie

Volumn 190, Issue 6, 2014, Pages 575-581

  Apostolova, Ivayla ^a,b   Hofheinz, F ^c   Buchert, R ^a   Steffen, I G ^a,b   Michel, R ^a   Rosner, C ^a   Prasad, V ^a   Kohler C ^a   Derlin, T ^d   Brenner, W ^a   Marnitz, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Positron emission tomography; Prognosis; Uterine cervical carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; WATER O 15;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD FLOW; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; EMISSION TOMOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; HYPOXIA; LIMIT OF QUANTITATION; ONCOLOGICAL PARAMETERS; PERFUSION; PILOT STUDY; RETROSPECTIVE STUDY; TISSUE PERFUSION; TUMOR CHARACTERIZATION; TUMOR PERFUSION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; VOXEL BASED MORPHOMETRY;

ADULT; AGED; BLOOD GLUCOSE; CERVIX UTERI; CHEMORADIOTHERAPY; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OXYGEN RADIOISOTOPES; PERFUSION IMAGING; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; REGIONAL BLOOD FLOW; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 84901585504     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-014-0611-7     Document Type: Article

References (28)

1. Brihaye C, Depresseux JC, Comar D (1995) Radiation dosimetry for bolus administration of oxygen-15-water. J Nucl Med 36:651-656
2. Dunnwald LK, Gralow JR, Ellis GK et al (2008) Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 26:4449-4457
3. Gillies RJ, Schornack PA, Secomb TW, Raghunand N (1999) Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1:197-207
4. Hansgen G, Kuhnt T, Pigorsch S et al (2002) Adjuvant simultaneous radiochemotherapy after operated uterine cervix carcinoma in high risk situation. Results of a pilot study. Strahlenther Onkol 178:71-77
5. Heinzelmann F, Henke G, Grafenstein M von et al (2012) Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer. Strahlenther Onkol 188:568-575
6. Hofheinz F, Langner J, Petr J et al (2012) A method for model-free partial volume correction in oncological PET. EJNMMI Res 2
7. Hofheinz F, P?zsch C, Oehme L et al (2012) Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets. Nuklearmedizin 51:9-16
8. Kimura H, Braun RD, Ong ET et al (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56:5522-5528
9. Klopp AH, Eifel PJ (2012) Biological predictors of cervical cancer response to radiation therapy. Semin Radiat Oncol 22:143-150
10. Komar G, Kauhanen S, Liukko K et al (2009) Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clin Cancer Res 15:5511-5517
11. Kunz-Schughart LA, Mueller-Klieser W, Vaupel P (2012) Tumor pathophysiology. Strahlenther Onkol 188(Suppl 3):299-303
12. Lin A, Hahn SM (2012) Hypoxia imaging markers and applications for radiation treatment planning. Semin Nucl Med 42:343-352
13. Ma DJ, Zhu JM, Grigsby PW (2011) Change in T2-fat saturation MRI correlates with outcome in cervical cancer patients. Int J Radiat Oncol Biol Phys 81:e707-e712
14. Mankoff DA, Dunnwald LK, Partridge SC, Specht JM (2009) Blood flow-metabolism mismatch: good for the tumor, bad for the patient. Clin Cancer Res 15:5294-5296
15. Marnitz S, Stromberger C, Kawgan-Kagan M et al (2010) Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity. Strahlenther Onkol 186:572-579
16. Miles KA, Williams RE (2008) Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 8:81-86
17. Movva S, Rodriguez L, Arias-Pulido H, Verschraegen C (2009) Novel chemotherapy approaches for cervical cancer. Cancer 115:3166-3180
18. Olsen JR, Dehdashti F, Siegel BA et al (2011) Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with preand posttreatment FDG-PET. Int J Radiat Oncol Biol Phys 81:772-777
19. Quinn MA, Benedet JL, Odicino F et al (2006) Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):S43-S103
20. Roberts C, Liyanage SH, Harry VN, Rockall AG (2011) Functional imaging for assessing tumor response in cancer of the cervix. Womens Health (Lond Engl) 7:487-497
21. Schuetz M, Schmid MP, Potter R et al (2010) Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncol 49:941-947
22. Siva S, Herschtal A, Thomas JM et al (2011) Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer. Cancer 117:3981-3988
23. Strauss HG, Kuhnt T, Laban C et al (2002) Chemoradiation in cervical cancer with cisplatin and highdose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 178:378-385
24. Surti S, Kuhn A, Werner ME et al (2007) Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med 48:471-480
25. Veldt AA van der, Hendrikse NH, Harms HJ et al (2010) Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer. J Nucl Med 51:1684-1690
26. Wouters BG, Brown JM (1997) Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat Res 147:541-550
27. Zhang Y, Chen JY, Xie CM et al (2011) Diffusionweighted magnetic resonance imaging for prediction of response of advanced cervical cancer to chemoradiation. J Comput Assist Tomogr 35:102-107
28. Zips D, Boke S, Kroeber T et al (2011) Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control. Strahlenther Onkol 187:306-310